The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary efficacy and safety of camrelizumab plus metronomic oral vinorelbine as first-line therapy for people aged 70 and above with advanced non-small cell lung cancer (NSCLC) from a phase II trial.
 
Lin Li
No Relationships to Disclose
 
Ping Zhang
No Relationships to Disclose
 
Jiayi Gao
No Relationships to Disclose
 
Min Tang
No Relationships to Disclose
 
Xin Nie
No Relationships to Disclose
 
Di Ma
No Relationships to Disclose
 
Zhe Zhao
No Relationships to Disclose
 
Yue Yuan
No Relationships to Disclose
 
Li Ding
No Relationships to Disclose
 
Chao Li
No Relationships to Disclose